Manage Your Risk
One of the biggest mistakes medtech companies make is thinking early interest in their technology is representative of the entire marketplace. It’s never a “no brainer,” especially in today’s disrupted and resource-constrained marketplace.
95% of medtech companies don’t fully understand evidence requirements of payers, health systems, and societies who set policy and influence reimbursement and adoption – and almost all of them start thinking about this too late.
An effective market access roadmap is vital to minimizing your time to market and maximizing your ROI and revenue, while an incomplete roadmap will stunt your market access growth for the life of your product. Take time now to ensure yours is robust.
Optimize Your Opportunity
You have many opportunities to optimize your commercialization pathway and accelerate adoption and payment of your technology. Our custom solutions, listed below, are a great place to start ideating and we hope you’ll find it informative. That said, we’re really old school and what we’re most passionate about is helping you, the innovators and leaders who can take healthcare forward. So we’d love to hear your story.
Overcome this Common Reimbursement Myth
Many companies clear the hurdle of regulatory approval only to come crashing into the brick wall created [...]
What’s Your Publication Track Record?
It takes three studies to triangulate on the conclusion your product is effective under real-world care scenarios. [...]
How We Help Companies of All Sizes
You Don't Have to Do It Alone Bringing medical devices, biotechnology, and precision medicine to market [...]
Know Where You Stand in the Product Lifecycle
Call Us, We’re Here For You